misonneh's cyp2d6 [25 articles] Export Sort

Recent papers added to misonneh's library classified by the tag cyp2d6. You can also see everyone's cyp2d6.

Hide details

	Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. [My Copy] Clinical pharmacokinetics, Vol. 48, No. 12. (2009), pp. 761-804. by Shu-Feng F. Zhou posted to review phenotype genetics cyp2d6 by misonneh on 2009-11-30 10:39:53 as
	Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. [My Copy] Clinical pharmacokinetics, Vol. 48, No. 11. (2009), pp. 689-723. by Shu-Feng F. Zhou posted to review phenotype genetics cyp2d6 by misonneh on 2009-11-30 10:36:14 as
	Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 242-251. by A. Gaedigk, L. Ndjountche, K. Divakaran, et al.L. DiAnne Bradford, I. Zineh, T. F. Oberlander, D. C. Brousseau, D. G. McCarver, J. A. Johnson, S. W. Alander, K. Wayne Riggs, J. Steven Leeder posted to heterogeneity genetics cyp2d6 by misonneh on 2009-11-19 05:28:27 as
	Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (23 October 2009), pp. 842-843. by Ke-Da Yu, Zhi-Ming Shao posted to tamoxifen review pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-11-19 05:26:25 as
	Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen. [My Copy] Cancer, Vol. 115, No. 5. (1 March 2009), pp. 952-961. by Masatsugu Okishiro, Tetsuya Taguchi, Seung Jin Kim, Kenzo Shimazu, Yasuhiro Tamaki, Shinzaburo Noguchi posted to tamoxifen pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:17:16 as along with 2 people ilsun Mi-Seon
	Impact of CYP2D610 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy. [My Copy] Cancer science*, Vol. 99, No. 5. (May 2008), pp. 995-999. by Kazuma Kiyotani, Taisei Mushiroda, Mitsunori Sasa, et al.Yoshimi Bando, Ikuko Sumitomo, Naoya Hosono, Michiaki Kubo, Yusuke Nakamura, Hitoshi Zembutsu posted to pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:12:50 as
	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. [My Copy] Journal of the National Cancer Institute, Vol. 97, No. 1. (5 January 2005), pp. 30-39. by Yan Jin, Zeruesenay Desta, Vered Stearns, et al.Bryan Ward, Herbert Ho, Kyung-Hoon H. Lee, Todd Skaar, Anna Maria M. Storniolo, Lang Li, Adjei Araba, Rebecca Blanchard, Anne Nguyen, Lynda Ullmer, Jill Hayden, Suzanne Lemler, Richard M. Weinshilboum, James M. Rae, Daniel F. Hayes, David A. Flockhart posted to tamoxifen pharmacogenetics genetics ddi cyp2d6 breast by misonneh on 2009-10-27 07:01:49 as along with 1 person frohike
	Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. [My Copy] Clinical pharmacology and therapeutics, Vol. 80, No. 1. (July 2006), pp. 61-74. by Silvana Borges, Zeruesenay Desta, Lang Li, et al.Todd C. Skaar, Bryan A. Ward, Anne Nguyen, Yan Jin, Anna Maria M. Storniolo, D. Michele Nikoloff, Lin Wu, Grant Hillman, Daniel F. Hayes, Vered Stearns, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism cyp2d6 breast by misonneh on 2009-10-27 07:01:06 as
	Germline pharmacogenetics of tamoxifen response: have we learned enough? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5147-5149. by Zeruesenay Desta, David A. Flockhart posted to tamoxifen pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-10-27 06:59:30 as
	Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen [My Copy] JAMA, Vol. 302, No. 13. (7 October 2009), pp. 1429-1436. by Werner Schroth, Matthew P. Goetz, Ute Hamann, et al.Peter A. Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J. Suman, Matthew M. Ames, Stephanie L. Safgren, Mary J. Kuffel, Hans U. Ulmer, Julia Bolander, Reiner Strick, Matthias W. Beckmann, Heinz Koelbl, Richard M. Weinshilboum, James N. Ingle, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch posted to tamoxifen prognosis prediction pharmacogenetics genotype cyp2d6 breast by misonneh on 2009-10-26 06:36:40 as along with 2 people songpku merpublic
	No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 18, No. 9. (September 2009), pp. 2562-2564. by Thomas P. Ahern, Lars Pedersen, Deirdre P. Cronin-Fenton, Henrik T. SÃ¸rensen, Timothy L. Lash posted to tamoxifen pharmacogenetics ddi cyp2d6 breast by misonneh on 2009-09-25 06:27:56 as
	CYP2D6 and tamoxifen: DNA matters in breast cancer [My Copy] Nat Rev Cancer, Vol. 9, No. 8. (August 2009), pp. 576-586. by Janelle M. Hoskins, Lisa A. Carey, Howard L. Mcleod posted to breast cyp2d6 pharmacogenetics resistance review tamoxifen by misonneh on 2009-07-27 08:49:07 as
	Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing? [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 7, No. 2. (February 2009), pp. 203-213. by M. J. Higgins, J. M. Rae, D. A. Flockhart, D. F. Hayes, V. Stearns posted to comments cyp2d6 pharmacogenetics tamoxifen by misonneh on 2009-04-14 06:20:53 as along with 1 person dbs
	Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. [My Copy] Annals of Oncology, Vol. 19, No. 1. (January 2008), pp. 56-61. by J. Gjerde, M. Hauglid, H. Breilid, et al.S. Lundgren, J. E. Varhaug, E. R. Kisanga, G. Mellgren, V. M. Steen, E. A. Lien posted to breast cyp2d6 sult1a1 tamoxifen by misonneh on 2009-01-23 08:32:56 as
	CYP2D6 phenotype prediction from genotype: which system is the best? [My Copy] Clinical pharmacology and therapeutics, Vol. 83, No. 2. (February 2008), pp. 225-227. by J. Kirchheiner posted to comments cyp2d6 phenotype by misonneh on 2009-01-23 08:30:24 as
	Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. [My Copy] Journal of Clinical Oncology, Vol. 25, No. 25. (1 September 2007), pp. 3837-3845. by H. S. Lim, Ju H. Lee, Seok K. Lee, Sook E. Lee, I. J. Jang, J. Ro posted to breast cyp2d6 pharmacogenetics pk tamoxifen by misonneh on 2009-01-23 08:27:21 as along with 2 people and 1 group lullaby HyeEun-Jeong Asian Pharmacogenetics Library
	Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response [My Copy] Clin Pharmacol Ther, Vol. 83, No. 1. (2007), pp. 160-166. by M. P. Goetz, A. Kamal, M. M. Ames posted to cyp2d6 pharmacogenetics review tamoxifen by misonneh on 2009-01-23 06:42:23 as
	A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients? [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 9. (7 May 2008), pp. 610-613. by D. F. Hayes, V. Stearns, J. Rae, D. Flockhart, posted to breast comments cyp2d6 modeling resistance tamoxifen by misonneh on 2008-11-19 05:18:07 as
	Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 18. (17 September 2008) by D. Gurwitz, W. Newman posted to breast comments cyp2d6 modeling pharmacogenetics survival tamoxifen by misonneh on 2008-11-19 05:17:27 as
	Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. [My Copy] Clinical Cancer Research, Vol. 14, No. 18. (15 September 2008), pp. 5864-5868. by M. P. Goetz, V. J. Suman, F. J. Couch, et al.M. M. Ames, J. M. Rae, M. G. Erlander, X. J. Ma, D. C. Sgroi, C. A. Reynolds, W. L. Lingle, R. M. Weinshilboum, D. A. Flockhart, Z. Desta, E. A. Perez, J. N. Ingle posted to breast cyp2d6 resistance tamoxifen by misonneh on 2008-11-19 05:16:43 as
	Impaired tamoxifen metabolism reduces survival in familial breast cancer patients. [My Copy] Clinical Cancer Research, Vol. 14, No. 18. (15 September 2008), pp. 5913-5918. by W. G. Newman, K. D. Hadfield, A. Latif, et al.S. A. Roberts, A. Shenton, C. Mchague, F. Lalloo, S. Howell, D. G. Evans posted to breast cyp2d6 resistance survival tamoxifen by misonneh on 2008-11-19 05:16:11 as
	Association between CYP2D6 10 genotype and survival of breast cancer patients receiving tamoxifen treatment. [My Copy] Annals of Oncology*, Vol. 19, No. 8. (1 August 2008), pp. 1423-1429. by Y. Xu, Y. Sun, L. Yao, et al.L. Shi, Y. Wu, T. Ouyang, J. Li, T. Wang, Z. Fan, T. Fan, B. Lin, L. He, P. Li, Y. Xie posted to breast cyp2d6 survival tamoxifen by misonneh on 2008-11-14 08:26:28 as along with 2 people and 1 group Mi-Seon panwei Asian Pharmacogenetics Library
	Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes. [My Copy] Journal of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5187-5193. by W. Schroth, L. Antoniadou, P. Fritz, et al.M. Schwab, T. Muerdter, U. M. Zanger, W. Simon, M. Eichelbaum, H. Brauch posted to breast cyp2c19 cyp2d6 pharmacogenetics tamoxifen by misonneh on 2008-09-16 21:33:40 as along with 1 person songpku
	Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 9. (7 May 2008), pp. 642-648. by Rinaa S. Punglia, Harold J. Burstein, Eric P. Winer, Jane C. Weeks posted to breast cyp2d6 modeling pharmacogenetics resistance tamoxifen by misonneh on 2008-09-16 21:31:38 as along with 1 person Mi-Seon
	Gene testing to tailor breast cancer therapy has arrived--is it ready for the clinic? [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 15. (6 August 2008), pp. 1050-1051. by G. Sinha posted to breast cyp2d6 pharmacogenetics tamoxifen by misonneh on 2008-09-16 21:30:22 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/cyp2d6

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

review	322
breast	263
genetics	175
epigenetics	162
methylation	153
pharmacogenetics	147
statistics	90
gwas	69
gene_specific_methylation	66
comments	65
biomarker	65
prognosis	61
association	59
meta_analysis	57
tamoxifen	53
chemotherapy	50
peripheral	47
moa	47
gxe	47
diet	43
folate	40
modeling	38
response	38
survival	36
resistance	36
guideline	35
prediction	33
global	33
adr	31
epidemiology	31
epistasis	30
prostate	28
korean	28
time_to_event	28
dynamic	28
technology	27
diagnosis	26
haplotype	26
cyp2d6	25
race	24
expression	23
neoadjuvant	22
database	21
colon	21
prevention	21
circ_dna	21
instability	21
environment	20
progression	19
phenotype	18
perspective	17
pooling	17
lung	17
risk_factor	17
clinic	16
line1	16
therapy	16
immunity	15
target_dna	14
invivo	13
1-carbon	13
randomized_controlled_trial	13
hr	13
kfdap_112909	13
tool	13
tutorial	12
age	12
5mdc	12
pk	11
mirna	11
data_mining	11
metastasis	11
gxg	11
hematology	11
design	11
estrogen	10
bladder	10
pathway	9
mdr1	9
exposure	9
her2	9
smoking	9
hormone	9
reproductive	8
esr1	8
fda	8
methodology	8
lifestyle	8
heterogeneity	8
cyp450	8
epilepsy	8
bias	8
cancer	8
gst	8
ivive	8
etiology	7
power	7
cnv	7
prenatal	7
hla	7
kim_	7
mthfr	7
trend	7
dnmt	7
subtypes	7
metabolism	7
drug_discovery	6
summary	6
system_biology	6
hyper_hypo	6
alcohol	6
cell	6
pcb	6
cohort	6
histone	6
maternal	6
dna_repair	6
carbamazepine	6
ddi	6
inheritance	5
fundamental_concept_s1	5
chemoprevention	5
mortality	5
benign	5
mgmt	5
array	5
translation	5
microarray	5
mhc	5
pet	5
nos3	5
intervention	5
cervix	5
ntissue	4
disparities	4
observation	4
leukemia	4
detection	4
bmd	4
balanced	4
cns	4
refractory	4
population	4
pathology	4
triple-negative	4
bayesian	4
cimp	4
basal-like	4
transport	4
biobank	4
linkage	4
tsnp	4
asian_populations	4
public	3
toxicity	3
fu	3
practice	3
ros	3
ovarian	3
cyp1a1	3
antioxidant	3
demethylation	3
cytokine	3
swog	3
12lecture	3
cluster	3
intrauterine	3
mds	3
sult1e1	3
glioblastoma	3
molecular	3
metformin	3
sult1a1	3
statin	3
validation	3
risk_assessment	3
hitchhiking	3
aml	3
egfr_pathway	3
protocol	2
pharmacogenomics	2
fprp	2
decitabine	2
specimen	2
pharmacodynamic	2
classification	2
phase	2
isoflavone	2
testicular	2
genotype	2
polycomb	2
ugt	2
nutrition	2
diabetes	2
tpmt	2
immortalization	2
radiotherapy	2
oral	2
wnt	2
quantitative_traits	2
anthracycline	2
brain	2
finasteride	2
consorcium	2
ovary	2
lymphoma	2
grail	2
toxicology	2
bisphenol	2
caret	2
iron	2
feature_selection	2
slco1b1	2
s8897	2
key	2
hematopoiety	2
ki67	2
irinotecan	2
aromatase_inhibitor	2
mnsod	2
brca12	2
parent_study	2
comt	2
cyp2c19	2
kawasaki	2
allergy	2
epigenetic_therapy	2
insilico	2
cyp2e1	2
apoptosis	2
childhood	2
benzopyrene	2
brca	2
definition	2
endometrix	2
atm	2
nqo1	2
aspirin	2
lactation	1
compliance	1
meta_anlaysis	1
fastsnp	1
myc	1
multiple_myeloma	1
aldh1	1
temozolomide	1
illumina	1
prevalence	1
journal_club	1
pax2	1
endpoint	1
twin_study	1
xrcc3	1
cml	1
decision	1
benzene	1
aldh2	1
read_	1
histology	1
cell_cycle_control	1
paternal	1
sat2	1
mbd2	1
interleukin	1
ho1	1
xrcc1	1
liver	1
rank	1
acs	1
gpx1	1
cyp1a2	1
ugt1a1	1
methotrexate	1
dag	1
series	1
resonse	1
silencing_rna	1
cyp2c9	1
history	1
s100p	1
psychoses	1
fmr1	1
5-alpha_reductase	1
rcc	1
nhs	1
sfrp5	1
steroid	1
azacitidine	1
catechol	1
obesity	1
tgf	1
consortium	1
cyp3a4	1
dcic	1
peakbmd	1
nrf2	1
oralscc	1
cyp1b1	1
mrp3	1
maspin	1
nsaid	1
gstp1	1
osteoporosis	1
inflammtion	1
opg	1
assay	1
phytoestrogen	1
lipidadjust	1
mining	1
cbr3	1
antidepressant	1
scn	1
rfc	1
meternal	1
hnscc	1
cisplatin	1
polyphenol	1
hogg1	1
confounder	1
cyclophosphamide	1
mpo	1
parity	1
oncotypedx	1
cdk	1
alternative	1
tp53	1
nuclear_receptor	1
alkylating_agents	1
stromal_component	1
tea	1
cat	1
infection	1
abacavir	1
digoxin	1
p53	1
metabolomics	1
index	1
ecadherin	1
xpd	1
polymapr	1
plink	1
mapping	1
family_hx	1
sputum	1
src	1
networking	1
glioma	1
neurod1	1
proression	1
bmp	1
splicing	1
hpv	1
fun	1
no	1
invitro	1
peripheral_blood	1
qsar	1
diganosis	1
example	1
multitest	1
cyp19	1
casp8	1
integration	1
pharmacokinetic_variability	1
heritability	1
hif1a	1
tgm2	1
outcome	1
warfarin	1
immunoprecipitation	1

misonneh's cyp2d6 [25 articles] Export Sort

misonneh's tags